Klinische Monatsblatter fur Augenheilkunde · 2018
[Possible Influencing Factors for the Prediction of Postoperative Visual Acuity Gain after Retroiridal Iris Claw Lens Implantation].
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Schmidt Isabell, Langenbucher Achim, Eppig Timo, Seitz Berthold
Аннотация
PURPOSE: To determine effect sizes for visual acuity (VA) and visual acuity gain (ΔVA, pre- to postoperative) after the implantation of retroiridal Verisyse iris-claw lenses.
MATERIALS AND METHODS: Nineteen eyes of 19 patients (mean age of 70 ± 17 years) who underwent retoriridal iris claw lens implantation were included. Inclusion criteria were a lack of capsular support and complete data of pre- and postoperative corrected visual acuity, optical biometry, accompanying diseases and previous surgical intervention. A generalized linear model was established with postoperative visual acuity and visual acuity gain as dependent variables. Effect sizes were pseudoexfoliation syndrome, trauma, sex, previous surgical interventions as factors and axial length, average keratometry and corneal astigmatism as covariates.
RESULTS: The mean visual acuity improved from 0.72 ± 0.65 logMAR preoperatively to 0.36 ± 0.39 logMAR postoperatively (ΔVA 0.36 ± 0.69 logMAR). The average refractive IOL power was 19.4 ± 4.9 dpt. For modelling of VA/ΔVA the axial length (p = 0.001)/axial length (p = 0.001) and preop VA (p < 0.001) were tailored out as effect sizes.
CONCLUSIONS: The axial length and preoperative VA affect postoperative visual acuity and visual acuity gain significantly. In eyes with lower preoperative visual acuity and in longer eyes larger visual acuity gain can be expected after retroiridal iris claw lens implantation.
MATERIALS AND METHODS: Nineteen eyes of 19 patients (mean age of 70 ± 17 years) who underwent retoriridal iris claw lens implantation were included. Inclusion criteria were a lack of capsular support and complete data of pre- and postoperative corrected visual acuity, optical biometry, accompanying diseases and previous surgical intervention. A generalized linear model was established with postoperative visual acuity and visual acuity gain as dependent variables. Effect sizes were pseudoexfoliation syndrome, trauma, sex, previous surgical interventions as factors and axial length, average keratometry and corneal astigmatism as covariates.
RESULTS: The mean visual acuity improved from 0.72 ± 0.65 logMAR preoperatively to 0.36 ± 0.39 logMAR postoperatively (ΔVA 0.36 ± 0.69 logMAR). The average refractive IOL power was 19.4 ± 4.9 dpt. For modelling of VA/ΔVA the axial length (p = 0.001)/axial length (p = 0.001) and preop VA (p < 0.001) were tailored out as effect sizes.
CONCLUSIONS: The axial length and preoperative VA affect postoperative visual acuity and visual acuity gain significantly. In eyes with lower preoperative visual acuity and in longer eyes larger visual acuity gain can be expected after retroiridal iris claw lens implantation.